The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Lysodren Shortage: What Providers and Prescribers Need to Know in 2026
Lysodren access challenges create real risks for ACC patients. This clinical guide for oncologists covers distribution, access resources, and how to minimize delays.
Malarone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Malarone (atovaquone/proguanil) availability in 2026: shortage status, stocking realities, prescribing implications, and practical alternatives for providers.
Mar-Cof CG Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Mar-Cof CG availability in 2026: why patients struggle to fill it, how to manage access issues, and when to consider alternatives.
Mavyret Shortage: What Providers and Prescribers Need to Know in 2026
A clinical resource for providers on Mavyret access challenges in 2026: prior authorization workflows, specialty pharmacy routing, alternatives, and patient assistance programs.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Mebendazole Shortage: What Providers and Prescribers Need to Know in 2026
Mebendazole (Emverm) is not in an FDA shortage, but the access landscape in 2026 is complex. Key clinical guidance for providers on prescribing, alternatives, and cost.
Mefloquine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on the 2024-2026 mefloquine shortage: current status, affected patient populations, alternative regimens, and when to contact CDC Malaria consultation.
Megestrol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of the 2025-2026 Megestrol acetate tablet shortage: affected strengths, alternatives by indication, and tools to help your patients maintain access.
Menest Shortage: What Providers and Prescribers Need to Know in 2026
Clinical briefing for providers on Menest (esterified estrogens) availability in 2026. Covers shortage context, therapeutic alternatives, dosing conversions, and patient communication strategies.
Mephyton (Phytonadione) Shortage: What Providers and Prescribers Need to Know in 2026
The Mephyton brand is discontinued. Here's what prescribers need to know about generic phytonadione availability, clinical alternatives, and how to help patients fill this prescription.
Methylergonovine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical update for OB/GYN providers and prescribers on the 2026 Methylergonovine shortage: supply timeline, prescribing implications, alternatives, and tools to help your patients.
Methylin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on the methylphenidate shortage in 2026: current status, prescribing strategies, alternative options, and resources to help your patients.
Metoclopramide Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on metoclopramide availability in 2026. Covers affected formulations, therapeutic substitutions, and patient management strategies.